Skip to main content
Zai Lab Limited logo

Zai Lab Limited — Investor Relations & Filings

Ticker · 9688 ISIN · KYG9887T1168 LEI · 549300P2UYQ9U5LY1T58 HKEX Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2021-08-10 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 9688

About Zai Lab Limited

http://www.zailaboratory.com

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing transformative therapies that address medical conditions with significant unmet needs. The company focuses its pipeline and development efforts across four core therapeutic areas: oncology, immunology, neuroscience, and infectious disease. Zai Lab employs a strategy of internal research and global partnerships to advance best-in-class and first-in-class medicines. A key commercial product is ZEJULA (niraparib), utilized as a maintenance treatment for ovarian cancer in markets including mainland China.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF THE 2021 INTERIM FINANCIAL RESULTS
Interim / Quarterly Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF THE 2021 INTERIM FINANCIAL RESULTS' and contains detailed unaudited financial results for the three and six months ended June 30, 2021. It includes comprehensive financial data, product highlights, corporate updates, and anticipated milestones for the remainder of the year. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or a certification. The content corresponds to a comprehensive financial report for a period shorter than a full fiscal year, specifically an interim (half-year) report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-08-10 English
Company Information Sheet
Regulatory Filings Classification · 95% confidence The document is a 'Company Information Sheet' from the HKEX (Hong Kong Stock Exchange) portal for Zai Lab Limited. It acts as a directory or index page providing links to various corporate governance and legal documents (Waivers, Foreign Laws, Constitutional Documents, Deposit Agreement). Since it is a short, navigational summary page rather than a primary financial or operational report, and it serves as a general regulatory disclosure of company information, it fits best under the 'Regulatory Filings' (RNS) category.
2021-08-02 English
Company Information Sheet
Regulatory Filings Classification · 95% confidence The document is titled 'Company Information Sheet' and is provided to give public information about Zai Lab Limited as of August 2, 2021. It includes detailed references to waivers and exemptions granted by the Hong Kong Stock Exchange and the Securities and Futures Commission (SFC), and discusses compliance with various Listing Rules and the Companies (WUMP) Ordinance. The document references the company's prospectus dated September 17, 2020, and includes detailed explanations about accounting standards adopted, disclosure requirements, and waivers related to the accountants' report and financial disclosures. The content is regulatory and compliance-focused, providing detailed information about waivers, exemptions, and disclosure practices rather than presenting financial statements or management commentary. It is not an annual report, interim report, earnings release, or audit report itself, but rather a regulatory disclosure document that informs about compliance with listing rules and exemptions granted. The document is lengthy (15,000 characters) and contains substantive information, not merely an announcement or a brief notice. Given the nature of the content—detailed regulatory compliance information and waivers related to listing rules and financial disclosures—it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2021-08-02 English
NOTICE OF BOARD ACTION AND DATE OF PUBLICATION OF 2021 INTERIM RESULTS ANNOUNCEMENT
Report Publication Announcement Classification · 95% confidence The document is a short announcement (2304 characters) from Zai Lab Limited regarding the upcoming approval and publication date of their 2021 interim results. It states that the audit committee will approve the unaudited interim results for the three and six months ended June 30, 2021, and that the results will be announced on a specific date. It also mentions a planned earnings teleconference call and webcast to discuss the results. The document does not contain the actual interim financial statements or substantive financial data but rather informs about the timing and process of the results release. According to the 'MENU VS MEAL' rule, this is an announcement about the publication of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2021-07-27 English
FIFTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is titled 'Fifth Amended and Restated Articles of Association' of Zai Lab Limited, adopted by a special resolution. It contains detailed provisions about the company's governance structure, definitions of terms, share issuance, rights of preferred shares, register of members, share certificates, and transfer of shares. This is a governance document outlining the internal rules and regulations of the company rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, audit information, earnings data, or voting results. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains the full text of the articles, not just an announcement or summary, supporting a high confidence classification.
2021-06-25 English
VOLUNTARY ANNOUNCEMENT - VOTING RESULTS OF ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the voting results from the Annual General Meeting (AGM) of Zai Lab Limited held on June 24, 2021. It details the approval of amendments to the Articles of Association and the ratification of auditors. The text explicitly states it is a "VOLUNTARY ANNOUNCEMENT VOTING RESULTS OF ANNUAL GENERAL MEETING" and provides detailed voting outcomes for each resolution. There is no full report or financial statements included, only the results of shareholder votes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 6457 characters, which is sufficient to contain detailed voting results rather than a brief notice. Therefore, the correct classification is DVA with high confidence.
2021-06-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.